The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. - Wikidata - wikimedia - TriplyDB

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

http://www.wikidata.org/entity/Q34590652

about

Community acquired bacterial pneumonia What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis.Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection.The impact of bacterial and viral co-infection in severe influenza Aetiology of community-acquired pneumonia among adults in an H1N1 pandemic year: the role of respiratory viruses.Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.Burden of pneumococcal disease in adults aged 65 years and older: an Australian perspective Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma.Clinical features of endemic community-acquired psittacosis.Evaluation of yield of currently available diagnostics by sample type to optimize detection of respiratory pathogens in patients with a community-acquired pneumonia Bacterial etiologies of five core syndromes: laboratory-based syndromic surveillance conducted in Guangxi, China.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Respiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controls Acute lower respiratory infections in ≥ 5 year -old hospitalized patients in Cambodia, a low-income tropical country: clinical characteristics and pathogenic etiology Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.Lower respiratory tract virus findings in mechanically ventilated patients with severe community-acquired pneumonia.Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients.Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010 Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.Mortality in healthcare-associated pneumonia in a low resistance setting: a prospective observational study Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.Role of the neutrophil-lymphocyte count ratio in the differential diagnosis between pulmonary tuberculosis and bacterial community-acquired pneumonia.Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia Systematic review and meta-analysis of a urine-based pneumococcal antigen test for diagnosis of community-acquired pneumonia caused by Streptococcus pneumoniae.Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study.Utility of oropharyngeal real-time PCR for S. pneumoniae and H. influenzae for diagnosis of pneumonia in adults.Legionella pneumophila lung abscess associated with immune suppression.Viral infection in patients with severe pneumonia requiring intensive care unit admission.Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians.Pneumonia in the developing world: Characteristic features and approach to management.The SMART-COP score performs well for pneumonia risk stratification in Australia's Tropical Northern Territory: a prospective cohort study.Community-acquired pneumonia in the central desert and north-western tropics of Australia.Impact of an antimicrobial stewardship intervention on appropriateness of prescribing for community-acquired pneumonia in an Australian regional hospital.Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia.Identification of pathogens by comprehensive real-time PCR versus conventional methods in community-acquired pneumonia in Japanese adults.Management of community-acquired pneumonia in an Australian regional hospital.

P2860

Q22241379-6A963D87-599D-4457-8ABB-0B267BEC5455 Q26852219-7A0BE1B3-BA9F-4D7D-AA70-2799028C79EE Q30234952-A1108043-6F61-4242-B8F8-3E6282D0BA2E Q30411633-9FC13B8D-6C10-4512-A3BF-9CCF2ED133F6 Q30415172-8AFAA918-A9CC-4CCC-B7E0-B94F4DBF763F Q30416227-6A900280-3FEE-4801-B37E-8F0AB464C7E8 Q30422390-63B3006E-5D8D-478D-B330-F3C9881950E1 Q33802151-5B2AF483-F9DC-40BA-A623-439329A3B362 Q33861071-D0CA963C-C3EF-4585-8917-CFB1B195862B Q34286621-63A4A031-672A-4C05-84D7-D5910B647E36 Q34292704-B0190C69-EC97-472E-8B9B-479D609F8AD7 Q34434577-D74ABE96-A257-446C-B235-6DDAE40D5F70 Q34478074-2DBA12AF-D96C-4A59-A42D-ADBC93F5621E Q34539087-8A3F6931-2A10-416B-AB50-C453BA85F0E7 Q34595933-3D89106B-6C37-4BD9-B188-A58D83B5C186 Q34658291-E072CCCB-4962-4545-8DCB-E95378AA9AE2 Q34802736-1857D8A1-BC55-4193-90FB-50BE63D81414 Q35008394-7686AFD4-B143-4472-8E03-5DCFDD2128D6 Q35102442-A585AD41-6C0C-4F1B-85BC-4C1E66075E6A Q35154780-B97A79E2-C9C2-4E22-8776-5469947A8559 Q35745680-626407CB-0423-40FF-9842-DEA3FCEF300C Q35980166-8619D2B8-A5B9-4378-A455-04CC6817CB4F Q36281234-C607F5F5-42F4-42F4-B9E3-50445A347244 Q36397026-6A5724F7-8848-49CC-B53B-6FD2B521F190 Q36506099-A4D05856-9D95-4443-A3FE-C9DB2E16439F Q36660469-65FD76B1-2478-4B63-9464-F83F85729B87 Q36676363-E432B0BB-0838-4269-9F56-8F9A35EC62A1 Q36971154-3709BF11-7B40-417B-8654-C15D92E2BDDD Q37640327-CE1D9230-55CE-418D-A6DC-F24A75204A7E Q37642097-3B6A2C32-0BB0-4140-8164-39BDCDFA6114 Q37995748-B27683F2-5506-4C97-8119-F628F13BB1DA Q38461590-8E226F40-EEC5-4E2D-8EDA-53B916FA8406 Q38646554-1149DEC4-439B-4E4F-B515-37901F4DB035 Q38691465-E5F2B192-EEA9-4043-AB28-2B8897FEE5E7 Q39402565-B8D45EEB-2B6F-48DC-85A7-07B6732A9B54 Q39416369-AC3415F6-AB1B-41FD-BDFC-F17D6D74AE54 Q40213153-222EFF2D-BB91-45A7-9E89-C14555835791 Q40243731-C6C9051F-1587-4866-AF89-A4415FAE75B7 Q40688918-917DDFD9-E705-4910-8A47-962AA81A5247 Q40863201-05B472ED-D24F-4E55-B629-7B279E692855

P2860

The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.

http://www.wikidata.org/entity/Q34590652

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The etiology of community-acqu ...... the most appropriate therapy.

@en

The etiology of community-acqu ...... the most appropriate therapy.

@nl

type

label

The etiology of community-acqu ...... the most appropriate therapy.

@en

The etiology of community-acqu ...... the most appropriate therapy.

@nl

prefLabel

The etiology of community-acqu ...... the most appropriate therapy.

@en

The etiology of community-acqu ...... the most appropriate therapy.

@nl

P1433

Q34590652-DBEC2F89-4910-4CC9-AACC-17A6B3DFC0FA

P1476

Q34590652-6CE2B48F-DCD5-4A0C-B79F-24F6126EC2F9

P2093

Q34590652-071148A1-86D2-4249-B425-B660D79B3EC1

Q34590652-09CC986D-6F53-422C-8E4E-0FD6BF741971

Q34590652-0DA790C1-A34D-4459-89D0-C063892385E9

Q34590652-157C349F-17A2-4520-BA1C-E7253BB3F5D4

Q34590652-196A8E26-0024-4EEA-9C3A-BE8C038CEE5C

Q34590652-3D4FD729-5187-4867-97DC-7D760143B625

Q34590652-546EEE88-A298-4E73-B129-8818F527D507

Q34590652-60C47331-C538-4CC1-813C-492EE5A271A2

Q34590652-66E3C513-9BE3-4A47-B005-33E7CE7CFAB8

Q34590652-930A7340-BB79-45BC-9AC9-B2A80E9CFFB0

P2860

Q34590652-002678BE-D28E-4E1A-8895-3381973C9CD7

Q34590652-008825B8-4CB0-4B37-A3B1-4CC2BBA51C2A

Q34590652-029BC5B0-DA49-4612-A224-A75C15A309EC

Q34590652-087A4867-21AA-4669-861B-4B9C569D1006

Q34590652-1458082F-26C9-459F-A803-D5EDF11083DF

Q34590652-2228F7E9-D7D2-47BF-9EEA-56D70BACF920

Q34590652-227F1631-BC7C-4992-95B3-2A0B1873B212

Q34590652-2BE15EB0-ED78-44D7-80CA-083952424A31

Q34590652-3567A797-2865-47A9-8A28-868566420430

Q34590652-3A7908A3-F39F-48AB-9DE4-B1010F5DF17C

P304

Q34590652-0D0566BD-5460-4AE3-A818-D467E896796A

P31

Q34590652-0F797D24-C8F7-4FD1-91F8-C4F83AD4A39F

P356

Q34590652-ACD0DB1C-2201-411B-AB2F-44B2CB76A2D3

P407

Q34590652-13064239-2046-49A4-BFA8-6F0DD6FD2DF5

P433

Q34590652-D3DD991E-9389-4DFD-B6F2-C5A21050DEBC

P478

Q34590652-C29670A9-C841-4E80-9613-1947423CAE85

P50

Q34590652-CC7C17C6-F767-492B-A5DD-6848B96F91E3

P577

Q34590652-C338A63F-17B9-434E-BE55-D1516BF56D27

P698

Q34590652-EBCC7247-3F7D-44CA-AB04-A8E1D61DF858

P921

Q34590652-AF60E0FA-39D3-4C62-BCFC-671FFD1024B2

P356

P1433

Clinical Infectious Diseases

P1476

The etiology of community-acqu ...... the most appropriate therapy.

@en

P2093

Alistair A Wright

http://www.w3.org/2001/XMLSchema#string

Andrew J Fuller

http://www.w3.org/2001/XMLSchema#string

Australian CAP Study Collaboration

http://www.w3.org/2001/XMLSchema#string

Barbara Johnson

http://www.w3.org/2001/XMLSchema#string

Barrie C Mayall

http://www.w3.org/2001/XMLSchema#string

Graeme R Nimmo

http://www.w3.org/2001/XMLSchema#string

Grant W Waterer

http://www.w3.org/2001/XMLSchema#string

John G Armstrong

http://www.w3.org/2001/XMLSchema#string

Keryn J Christiansen

http://www.w3.org/2001/XMLSchema#string

M L Grayson

http://www.w3.org/2001/XMLSchema#string

P2860

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

Extended-spectrum beta-lactamases: a clinical update

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

A prediction rule to identify low-risk patients with community-acquired pneumonia

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia.

Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatmen

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?

Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan.

P304

1513-1521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/586749

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18419484

http://www.w3.org/2001/XMLSchema#string

P921